Drug Screening Near Me

A urine drug screen (UDS) analyzes a urine specimen for drugs and their metabolites. It is the most commonly used testing method in workplace and regulated programs because it is non-invasive, cost-effective, and detects a broad range of substances across a practical detection window.

• Collected under chain-of-custody conditions for regulated testing.
• Detects parent drugs and/or metabolites excreted in urine.
• Indicates prior exposure within a detection window, not current impairment.

Why Organizations Use Urine Drug Screening

• Pre-employment screening to help maintain a safe, drug-free workplace.
• Random, post-accident, reasonable suspicion, and return-to-duty testing.
• Compliance with regulatory requirements in safety-sensitive industries.
• Monitoring adherence to prescribed medications or treatment programs.

How It Works

Collection

• Donor provides a specimen in a secure container (observed or unobserved per program rules).
• Specimen validity checks may include creatinine, specific gravity, and pH.

Testing Methodology

• Initial immunoassay screen for rapid, cost-effective evaluation.
• Confirmatory testing (e.g., GC/MS or LC/MS/MS) for presumptive positives.
• Cutoff concentrations (ng/mL) determine positive/negative outcomes.

Interpreting Results

• Negative: No drug/metabolite detected above the cutoff.
• Positive: Drug/metabolite detected above the cutoff; requires confirmation and review.
• Validity issues: Diluted, adulterated, or substituted specimens may be cancelled or require recollection.

Detection Windows

Detection varies by substance, frequency of use, metabolism, hydration, body composition, and test sensitivity. Generally, many drugs are detectable for 1–3 days, while certain substances (e.g., cannabinoids in chronic use) can be detectable longer.

Key Considerations for Regulated (e.g., DOT) Programs

• Follow the applicable federal regulations and use certified laboratories.
• Use trained, qualified collectors and maintain strict chain-of-custody.
• Include specimen validity testing to deter tampering/adulteration.
• Have results reviewed by a qualified Medical Review Officer (MRO) when required.
• Document procedures, maintain records, and define clear follow-up steps after positive results.

Benefits and Limitations

Benefits

• Widely accepted and cost-effective for broad substance coverage.
• Balanced detection window appropriate for workplace monitoring.

Limitations

• Does not indicate real-time impairment.
• Potential for false positives/negatives without confirmation.
• May miss very recent use outside the detection window.

Best Practices for Implementation

• Adopt a clear written policy covering test reasons, panels, cutoffs, confidentiality, and consequences.
• Use a two-step approach: screening assay followed by confirmatory testing.
• Educate employees and donors about the process and expectations.
• Track positivity trends to inform safety and wellness initiatives.
• Partner with reliable collection networks and accredited laboratories.

Summary

Urine drug screening is a foundational tool for safety, compliance, and risk management. With certified procedures, defensible chain-of-custody, confirmatory testing, and qualified review, organizations can rely on UDS to identify prior substance exposure and support a safe, productive environment.

What Is a Hair Drug Screen?

Hair drug screening analyzes a small hair sample to detect the presence of drugs and their metabolites that have circulated in the bloodstream and become embedded in the hair shaft. Because hair grows slowly and stores drug metabolites for months, it provides one of the longest detection windows of all testing methods—ideal for identifying chronic or long-term substance use.

• Typically requires 100–120 strands cut close to the scalp (about 1.5 inches of hair).
• Represents approximately a 90-day detection period, depending on hair length.
• Can test for a wide range of substances including amphetamines, opioids, cocaine, marijuana, and PCP.

Why Organizations Use Hair Drug Screening

• Pre-employment testing for long-term substance use identification.
• Random or periodic workplace testing in safety-sensitive industries.
• Compliance monitoring in treatment or legal programs.
• Confirmation of lifestyle abstinence or compliance with company drug-free policies.

How It Works

Collection

• A collector trims a small sample (usually from the crown area) under chain-of-custody procedures.
• The sample is sealed, labeled, and shipped to a certified laboratory.
• Alternate collection sites (body hair) may be used if scalp hair is unavailable.

Testing Methodology

• Samples are washed and prepared to remove external contamination.
• Initial screening uses immunoassay technology to detect drug classes.
• Positive screens are confirmed with GC/MS or LC/MS/MS testing for precise identification.
• Cutoff levels are established in nanograms per milligram (ng/mg) per SAMHSA and laboratory standards.

Interpreting Results

• Negative: No drug/metabolite detected above the laboratory cutoff level.
• Positive: Drug/metabolite detected and confirmed through secondary testing.
• Inconclusive/Rejected: Insufficient sample or contamination requiring recollection.

Detection Windows

Hair testing provides the longest detection window of any drug testing method. A standard 1.5-inch hair sample reflects roughly 90 days of potential drug exposure. Longer samples may extend the window further, depending on growth rate (about 0.5 inches per month). Unlike urine or oral fluid testing, hair analysis does not detect very recent use (within the past 7–10 days).

Key Considerations for Regulated and Non-Regulated Testing

• Although DOT regulations currently do not require hair testing, the Department of Transportation and HHS continue to evaluate guidelines for possible adoption.
• For non-DOT programs, hair testing is accepted as an effective long-term detection tool.
• Collection should be performed by trained, qualified personnel under documented chain-of-custody.
• Laboratories should be certified under SAMHSA or CAP/CLIA accreditation for accuracy and reliability.

Benefits

• Long detection window (up to 90 days or more).
• Difficult to adulterate or substitute compared to urine specimens.
• Provides a clear pattern of chronic or repeated use.
• Collection is quick, non-invasive, and requires no restroom facilities.

Limitations

• Does not detect very recent drug use (typically within 7–10 days).
• Can be affected by cosmetic treatments or limited hair growth.
• Not currently an approved matrix for DOT-mandated testing (urine and oral fluid are).

Best Practices for Implementation

• Use a written policy specifying when and why hair testing will be used.
• Train collectors on proper sample size, collection location, and sealing procedure.
• Select laboratories with advanced analytical capabilities and SAMHSA compliance.
• Communicate to employees the differences between hair, urine, and oral fluid testing.
• Maintain confidentiality and consistent documentation across all testing activities.

Summary

Hair drug screening is a powerful and reliable method for detecting long-term drug use, making it an excellent option for employers, legal entities, and treatment programs seeking a comprehensive view of an individual’s drug history. When performed by trained collectors and analyzed in certified labs, hair testing provides defensible, tamper-resistant results that help maintain workplace integrity and safety.